0001593318-22-000001.txt : 20220125 0001593318-22-000001.hdr.sgml : 20220125 20220125142541 ACCESSION NUMBER: 0001593318-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220125 DATE AS OF CHANGE: 20220125 EFFECTIVENESS DATE: 20220125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synchronicity Pharma, Inc. CENTRAL INDEX KEY: 0001593318 IRS NUMBER: 711047315 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-430716 FILM NUMBER: 22553100 BUSINESS ADDRESS: STREET 1: 5205 PROSPECT ROAD STREET 2: #133-135 CITY: SAN JOSE STATE: CA ZIP: 95129 BUSINESS PHONE: (650) 235-4140 MAIL ADDRESS: STREET 1: 5205 PROSPECT ROAD STREET 2: #133-135 CITY: SAN JOSE STATE: CA ZIP: 95129 FORMER COMPANY: FORMER CONFORMED NAME: ReSet Therapeutics, Inc. DATE OF NAME CHANGE: 20160218 FORMER COMPANY: FORMER CONFORMED NAME: Reset Therapeutics, Inc. DATE OF NAME CHANGE: 20131203 D 1 primary_doc.xml X0708 D LIVE 0001593318 Synchronicity Pharma, Inc. 1416 Saratoga Avenue #133 SAN JOSE CA CALIFORNIA 95129 (650) 235-4140 DELAWARE Sircadian, Inc. ReSet Therapeutics, Inc. Reset Therapeutics, Inc. Corporation true Frederick B Craves 1416 Saratoga Avenue #133 San Jose CA CALIFORNIA 95129 Director Steve Kay 1416 Saratoga Avenue #133 San Jose CA CALIFORNIA 95129 Director Glenn Batchelder 1416 Saratoga Avenue #133 San Jose CA CALIFORNIA 95129 Executive Officer Director Blair Jackson 1416 Saratoga Avenue #133 San Jose CA CALIFORNIA 95129 Director Shu Kurosaki Glenn Batchelder #133 #133 CA CALIFORNIA 95129 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-01-11 false true true true false 0 3000000 1600000 1400000 false 3 0 0 0 false Synchronicity Pharma, Inc. /s/ Shu Kurosaki Shu Kurosaki Chief Financial Officer 2022-01-25